Although anti-PEG and anti-drug antibodies adversely affected efficacy of PEGylated uricase used in gout, the same was not true in large clinical trials of certolizumab pegol, a PEGylated anti-tumor necrosis factor Fab used in rheumatoid arthritis. This evidence concerns the gene TNF and gout.